AbbVie
ABBV
#30
Rank
C$635.34 B
Marketcap
C$359.60
Share price
4.20%
Change (1 day)
41.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$0.21 B148.17%
2025C$86.68 M-56.05%
2024C$0.19 B-13.93%
2023C$0.22 B-63.52%
2022C$0.62 B629.28%
2021C$86.13 M-77.97%
2020C$0.39 B85.64%
2019C$0.21 B-52.97%
2018C$0.44 B269.88%
2017C$0.12 B-48.45%
2016C$0.23 B-37.53%
2015C$0.37 B-44.13%
2014C$0.67 B2387.79%
2013C$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
C$63.7 MC$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$65.5 MC$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$0.16 BC$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$4.95 MC$53.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$14.61 MC$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$5.5 MC$63.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
N/AC$0.15 B๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$54.36 MC$0.23 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$53.4 MC$65.39 M๐Ÿ‡บ๐Ÿ‡ธ USA